Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

4 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
May 27, 2020 IBIO S 11,250 $1.61 $18,112 0 Direct -100.00% Disposed -99.9% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
May 27, 2020 IBIO Stock Option (right to buy) Common Stock (11,250) $0.93 Feb. 20, 2024 11,250 Disposed
Feb. 20, 2019 IBIO Stock Option (right to buy) Common Stock (15,000) $4.00 March 1, 2027 15,000 Disposed
Feb. 20, 2019 IBIO Stock Option (right to buy) Common Stock (11,250) $0.93 Feb. 20, 2024 11,250 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
April 5, 2017 IBIO Stock Option (right to buy)→ Common Stock (150,000) 150,000 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2020 $275,000 $100,000 · · · · $72,374 $447,374
2018 · · · · · · · ·
2017 $66,667 $20,000 · $52,966 · · · $139,633

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.